Related Experiment Video
Updated: Jul 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statin therapy: is the percent reduction or the attained low-density lipoprotein cholesterol level more important?
Tracie C Collins1, Peter H Jones
1Division of General Internal Medicine, University of Minnesota, 420 Delaware Street SE, MMC 451, Minneapolis, MN 55455, USA. tcc@umn.edu
Insights
Lowering low-density lipoprotein cholesterol (LDL-C) is crucial for preventing cardiovascular events. This review examines whether focusing on LDL-C reduction percentage or absolute LDL-C levels offers superior preventive care for high-risk patients.
Area of Science:
- Cardiology
- Preventive Medicine
- Pharmacology
Background:
- Hyperlipidemia is a significant risk factor for atherosclerosis.
- Lowering low-density lipoprotein cholesterol (LDL-C) reduces mortality and cardiovascular events.
- Current guidelines suggest LDL-C goals below 100 mg/dL, with lower targets for very high-risk individuals.
Purpose of the Study:
- To review the role of percent LDL-C reduction versus attained LDL-C levels as targets for statin therapy.
- To evaluate optimal management strategies for high-risk patients with hyperlipidemia.
Main Methods:
- Literature review of clinical trials and guidelines.
- Analysis of studies comparing LDL-C reduction percentage and absolute LDL-C levels.
- Discussion of statin therapy effectiveness in achieving lipid goals.
Main Results:
- Evidence supports the importance of both LDL-C reduction and absolute levels.
- Lower attained LDL-C levels may be more beneficial for very high-risk patients.
- Statin therapy is a cornerstone in managing hyperlipidemia and preventing cardiovascular disease.
Conclusions:
- The optimal target for statin therapy may involve a combination of percent reduction and absolute LDL-C levels.
- Individualized treatment strategies are essential for maximizing preventive care in high-risk populations.
- Further research is needed to define precise targets for diverse patient groups.
Abstract:
Hyperlipidemia is a well-known risk factor for atherosclerosis. Several trials have demonstrated the importance of lowering low-density lipoprotein cholesterol (LDL-C) levels to reduce all-cause mortality, coronary ischemia, and cerebrovascular accidents. Although the optimal goal for LDL-C levels in patients with known coronary heart disease has been less than 100 mg/dL, more recent findings support achieving even lower LDL-C levels for very high-risk patients. As the target levels for LDL-C trend towards lower values, it is important to evaluate the status for optimal management with statin therapy. In this review article, we discuss the role of percent LDL-C reduction versus attained LDL-C levels as targets for statin therapy in order to maximize the preventive care provided to high-risk patients.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care